Core Points - Baicheng Pharmaceutical announced on November 5 that its directors and senior management plan to reduce their shareholdings [1] Summary by Category Shareholding Reduction - Director and senior management member Jia Fei holds 48,908 shares (0.0451% of total shares) and plans to reduce his holdings by up to 12,200 shares (0.0112% of total shares) within three months after the disclosure of the reduction plan [1] - Senior management member Chen An holds 45,000 shares (0.0415% of total shares) and plans to reduce his holdings by up to 11,200 shares (0.0103% of total shares) within the same timeframe [1] - The company has received notifications from Jia Fei and Chen An confirming the completion of their share reduction plans [1]
百诚医药：关于部分董事、高级管理人员减持计划实施完毕公告